GateHouse Bio (fka sRNAlytics) is a startup based in the United States, 1 tracked investor.
GateHouse Bio (fka sRNAlytics) is a startup founded in 2020 based in the United States. Brouky records 1 investor associated with the company.
GateHouse Bio develops RNA-targeting therapeutics using proprietary small RNA technology to address genetic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.